183 related articles for article (PubMed ID: 32393213)
1. Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
Kabir S; Tahir Z; Mukhtar N; Sohail M; Saqalein M; Rehman A
BMC Pulm Med; 2020 May; 20(1):138. PubMed ID: 32393213
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
Chaoui I; Oudghiri A; El Mzibri M
J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301
[TBL] [Abstract][Full Text] [Related]
3. Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.
Singhal R; Reynolds PR; Marola JL; Epperson LE; Arora J; Sarin R; Myneedu VP; Strong M; Salfinger M
J Clin Microbiol; 2016 Sep; 54(9):2298-305. PubMed ID: 27335153
[TBL] [Abstract][Full Text] [Related]
4. Emergence of Specific
Singh PK; Singh U; Jain A
Microb Drug Resist; 2021 May; 27(5):647-651. PubMed ID: 32991238
[No Abstract] [Full Text] [Related]
5. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.
Niward K; Ängeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schön T
J Antimicrob Chemother; 2016 Feb; 71(2):333-8. PubMed ID: 26538509
[TBL] [Abstract][Full Text] [Related]
7. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
[TBL] [Abstract][Full Text] [Related]
8. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.
Surcouf C; Heng S; Pierre-Audigier C; Cadet-Daniel V; Namouchi A; Murray A; Gicquel B; Guillard B
BMC Infect Dis; 2011 Sep; 11():255. PubMed ID: 21955640
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
[TBL] [Abstract][Full Text] [Related]
11. Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.
Zhang D; Gomez JE; Chien JY; Haseley N; Desjardins CA; Earl AM; Hsueh PR; Hung DT
Antimicrob Agents Chemother; 2016 Nov; 60(11):6600-6608. PubMed ID: 27572408
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
[TBL] [Abstract][Full Text] [Related]
13. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
[TBL] [Abstract][Full Text] [Related]
14. Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India.
Chawla K; Kumar A; Shenoy VP; Chakrabarty S; Satyamoorthy K
J Glob Antimicrob Resist; 2018 Jun; 13():250-253. PubMed ID: 29421317
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis.
Ando H; Mitarai S; Kondo Y; Suetake T; Kato S; Mori T; Kirikae T
J Med Microbiol; 2011 Feb; 60(Pt 2):184-188. PubMed ID: 21051549
[TBL] [Abstract][Full Text] [Related]
16. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
Avalos E; Catanzaro D; Catanzaro A; Ganiats T; Brodine S; Alcaraz J; Rodwell T
PLoS One; 2015; 10(3):e0120470. PubMed ID: 25816236
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR.
van Doorn HR; An DD; de Jong MD; Lan NT; Hoa DV; Quy HT; Chau NV; Duy PM; Tho DQ; Chinh NT; Farrar JJ; Caws M
Int J Tuberc Lung Dis; 2008 Jul; 12(7):736-42. PubMed ID: 18544197
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone resistance mutations among
Dixit R; Mohan E; Gupta A; Gupta PS; Patni T; Goyal M; Meena RK
Int J Mycobacteriol; 2023; 12(3):294-298. PubMed ID: 37721235
[TBL] [Abstract][Full Text] [Related]
19. Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
Sidiq Z; Hanif M; Dwivedi KK; Chopra KK; Khanna A; Vashishat BK
Indian J Tuberc; 2023 Jul; 70(3):361-365. PubMed ID: 37562913
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control.
Jabeen K; Shakoor S; Malik F; Hasan R
Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():47-8. PubMed ID: 27128617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
